Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) Institutional Ownership

13F Institutional Holders and Ownership History for Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
DMII on Nasdaq
Shares outstanding
65,767,971
Price per share
$9.95
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
34,724,554
Total reported value
$342,890,571
% of total 13F portfolios
0%
Share change
+34,039,594
Value change
+$336,109,467
Number of holders
51
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Drugs Made In America Acquisition II LLC 10% 6,708,333 Drugs Made In America Acquisition II LLC 01 Oct 2025

As of 31 Dec 2025, 51 institutional investors reported holding 34,724,554 shares of Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII). This represents 53% of the company’s total 65,767,971 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) together control 45% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Magnetar Financial LLC 4.1% 2,700,000 0.26% $26,730,000
Glazer Capital, LLC 3.6% 2,349,899 0.61% $23,264,000
First Trust Capital Management L.P. 3.1% 2,068,118 1.2% $20,474,368
Hudson Bay Capital Management LP 3% 1,969,030 0.11% $19,493,397
TENOR CAPITAL MANAGEMENT Co., L.P. 2.3% 1,500,000 0.21% $14,850,000
MILLENNIUM MANAGEMENT LLC 2.3% 1,500,000 0.01% $14,850,000
Polar Asset Management Partners Inc. 2.3% 1,500,000 0.29% $14,850,000
HGC Investment Management Inc. 1.9% 1,230,980 2.6% $12,186,702
AQR Arbitrage LLC 1.8% 1,151,400 0.24% $11,398,860
Karpus Management, Inc. 1.7% 1,143,625 0.35% $11,321,888
ARISTEIA CAPITAL, L.L.C. 1.7% 1,100,000 0.31% $10,890,000
WOLVERINE ASSET MANAGEMENT LLC 1.6% 1,062,773 0.15% $10,521,453
OMERS ADMINISTRATION Corp 1.5% 1,000,000 0.07% $9,900,000
D. E. Shaw & Co., Inc. 1.5% 1,000,000 0.01% $9,900,000
Davidson Kempner Capital Management LP 1.5% 1,000,000 0.22% $9,900,000
TWO SIGMA INVESTMENTS, LP 1.3% 886,544 0.01% $8,776,786
PICTON MAHONEY ASSET MANAGEMENT 1.3% 875,000 0.09% $8,662,500
CSS LLC/IL 1.2% 806,001 0.45% $7,979,410
HighTower Advisors, LLC 1.2% 789,614 0.01% $7,817,179
MOORE CAPITAL MANAGEMENT, LP 1.1% 750,000 0.15% $7,425,000
Ghisallo Capital Management LLC 1.1% 750,000 0.33% $7,425,000
Context Capital Management, LLC 1.1% 750,000 0.19% $7,425,000
Radcliffe Capital Management, L.P. 0.88% 575,607 0.31% $5,698,509
HBK INVESTMENTS L P 0.76% 500,000 0.05% $4,950,000
Sculptor Capital LP 0.76% 500,000 0.06% $4,950,000

Institutional Holders of Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 34,724,554 $342,890,571 +$336,109,467 $9.90 51